EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 32021M10165
Commission Decision of 05/07/2021 declaring a concentration to be compatible with the common market (Case No COMP/M.10165 - ASTRAZENECA / ALEXION PHARMACEUTICALS) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)
Id-Deċiżjoni tal-Kummissjoni ta' 05/07/2021 li tiddikjara konċentrazzjoni hija kompatibbli mas-suq komuni (il-Każ Nru COMP/M.10165 - ASTRAZENECA / ALEXION PHARMACEUTICALS) skond ir-Regolament tal-Kunsill (KE) Nru 139/2004 (It-test bl-Ingliż biss huwa awtentiku)
Id-Deċiżjoni tal-Kummissjoni ta' 05/07/2021 li tiddikjara konċentrazzjoni hija kompatibbli mas-suq komuni (il-Każ Nru COMP/M.10165 - ASTRAZENECA / ALEXION PHARMACEUTICALS) skond ir-Regolament tal-Kunsill (KE) Nru 139/2004 (It-test bl-Ingliż biss huwa awtentiku)
In force